vs
Amarin Corp plc(AMRN)与GETTY REALTY CORP(GTY)财务数据对比。点击上方公司名可切换其他公司
GETTY REALTY CORP的季度营收约是Amarin Corp plc的1.3倍($57.8M vs $45.1M),GETTY REALTY CORP净利率更高(46.0% vs -23.3%,领先69.3%),GETTY REALTY CORP同比增速更快(10.5% vs 7.0%),过去两年GETTY REALTY CORP的营收复合增速更高(7.6% vs -18.3%)
Amarin是一家1993年成立的爱裔美籍生物制药企业,总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物,已推出处方级Omega-3脂肪酸药物Vascepa(AMR-101)。
Getty Realty Corp是一家总部位于美国的上市房地产投资信托(REIT),主要持有、租赁并管理商业地产资产组合,核心资产涵盖便利店、加油站及配套零售物业,业务覆盖美国多个州,服务零售与能源领域的优质租户。
AMRN vs GTY — 直观对比
营收规模更大
GTY
是对方的1.3倍
$45.1M
营收增速更快
GTY
高出3.5%
7.0%
净利率更高
GTY
高出69.3%
-23.3%
两年增速更快
GTY
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $45.1M | $57.8M |
| 净利润 | $-10.5M | $26.6M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 66.1% |
| 净利率 | -23.3% | 46.0% |
| 营收同比 | 7.0% | 10.5% |
| 净利润同比 | 33.0% | 80.1% |
| 每股收益(稀释后) | — | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AMRN
GTY
| Q1 26 | $45.1M | $57.8M | ||
| Q4 25 | $49.2M | $60.5M | ||
| Q3 25 | $49.7M | $55.6M | ||
| Q2 25 | $72.7M | $53.3M | ||
| Q1 25 | $42.0M | $52.3M | ||
| Q4 24 | $62.3M | $53.0M | ||
| Q3 24 | $42.3M | $51.5M | ||
| Q2 24 | $67.5M | $49.9M |
净利润
AMRN
GTY
| Q1 26 | $-10.5M | $26.6M | ||
| Q4 25 | $-1.2M | $27.0M | ||
| Q3 25 | $-7.7M | $23.3M | ||
| Q2 25 | $-14.1M | $14.0M | ||
| Q1 25 | $-15.7M | $14.8M | ||
| Q4 24 | $-48.6M | $22.3M | ||
| Q3 24 | $-25.1M | $15.3M | ||
| Q2 24 | $1.5M | $16.7M |
毛利率
AMRN
GTY
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率
AMRN
GTY
| Q1 26 | 35.5% | 66.1% | ||
| Q4 25 | -12.9% | 67.3% | ||
| Q3 25 | -22.4% | 62.5% | ||
| Q2 25 | -22.0% | 46.7% | ||
| Q1 25 | -39.9% | 50.5% | ||
| Q4 24 | -84.3% | 61.6% | ||
| Q3 24 | -59.5% | 48.9% | ||
| Q2 24 | -0.8% | 52.5% |
净利率
AMRN
GTY
| Q1 26 | -23.3% | 46.0% | ||
| Q4 25 | -2.5% | 44.7% | ||
| Q3 25 | -15.6% | 42.0% | ||
| Q2 25 | -19.4% | 26.3% | ||
| Q1 25 | -37.4% | 28.3% | ||
| Q4 24 | -78.0% | 42.1% | ||
| Q3 24 | -59.4% | 29.8% | ||
| Q2 24 | 2.3% | 33.5% |
每股收益(稀释后)
AMRN
GTY
| Q1 26 | — | $0.43 | ||
| Q4 25 | $0.00 | $0.46 | ||
| Q3 25 | $-0.02 | $0.40 | ||
| Q2 25 | $-0.03 | $0.24 | ||
| Q1 25 | $-0.04 | $0.25 | ||
| Q4 24 | $-0.12 | $0.38 | ||
| Q3 24 | $-0.06 | $0.27 | ||
| Q2 24 | $0.00 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $3.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | — |
| 总资产 | $645.8M | $2.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
AMRN
GTY
| Q1 26 | $307.8M | $3.7M | ||
| Q4 25 | $302.6M | $8.4M | ||
| Q3 25 | $286.6M | $5.2M | ||
| Q2 25 | $298.7M | $7.5M | ||
| Q1 25 | $281.8M | $6.3M | ||
| Q4 24 | $294.2M | $9.5M | ||
| Q3 24 | $305.7M | $4.0M | ||
| Q2 24 | $306.7M | $4.7M |
总债务
AMRN
GTY
| Q1 26 | — | — | ||
| Q4 25 | — | $995.0M | ||
| Q3 25 | — | $934.6M | ||
| Q2 25 | — | $919.2M | ||
| Q1 25 | — | $901.4M | ||
| Q4 24 | — | $904.3M | ||
| Q3 24 | — | $833.9M | ||
| Q2 24 | — | $838.4M |
股东权益
AMRN
GTY
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $1.1B | ||
| Q3 25 | $458.9M | $1.0B | ||
| Q2 25 | $464.9M | $982.4M | ||
| Q1 25 | $473.7M | $961.1M | ||
| Q4 24 | $486.2M | $962.1M | ||
| Q3 24 | $531.4M | $963.4M | ||
| Q2 24 | $551.9M | $951.0M |
总资产
AMRN
GTY
| Q1 26 | $645.8M | $2.2B | ||
| Q4 25 | $670.8M | $2.2B | ||
| Q3 25 | $659.8M | $2.1B | ||
| Q2 25 | $670.1M | $2.0B | ||
| Q1 25 | $655.7M | $2.0B | ||
| Q4 24 | $685.3M | $2.0B | ||
| Q3 24 | $750.6M | $1.9B | ||
| Q2 24 | $799.9M | $1.9B |
负债/权益比
AMRN
GTY
| Q1 26 | — | — | ||
| Q4 25 | — | 0.93× | ||
| Q3 25 | — | 0.92× | ||
| Q2 25 | — | 0.94× | ||
| Q1 25 | — | 0.94× | ||
| Q4 24 | — | 0.94× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
GTY
暂无分部数据